In Q3 2025, GE HealthCare Technologies Inc. reported $5.7B in quarterly revenue and a net income of $589M. This represents an impressive growth rate of 10.77% on a quarter-over-quarter (QoQ) basis and 7.13% year-over-year (YoY). Despite this strong performance, the company's operating margin fell slightly below the sector average at 13.39%, while its net margin landed at 10.11%.
Looking ahead, GE HealthCare continues to show promising growth prospects across several key markets. The telecardiology market, in particular, is expected to reach USD 43.08 billion by 2033, driven by advancements in technology. Additionally, the medical equipment maintenance market is projected to grow at a CAGR of 10.04% between 2025 and 2034, reaching a value of USD 121.94 billion by 2034. The radiology AI and mechanical ventilators markets also present significant growth opportunities for the company.
However, there are potential concerns that could impact GE HealthCare's profitability. Tariff costs have contributed to a decline in the net income margin of 320 basis points and an adjusted EBIT margin of 200 basis points. Furthermore, unfavorable mix may continue to put pressure on the company's margins.
Despite these challenges, GE HealthCare remains well-positioned for long-term growth due to its strong product offerings and presence in high-growth markets. Investors should carefully consider the potential risks alongside the compelling investment opportunities presented by this company. With ongoing innovation and strategic investments, GE HealthCare Technologies Inc. is poised to continue its upward trajectory in the healthcare sector.